Rosenblum Mark J 4
4 · Salarius Pharmaceuticals, Inc. · Filed Jul 16, 2020
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Stock Option (right to buy)
2020-07-14+49,955→ 49,955 totalExercise: $1.32Exp: 2030-07-13→ Common Stock (49,955 underlying)
Footnotes (1)
- [F1]25% of the options are fully vested on July 14, 2021, and 1/36 of the remaining options vest on each monthly anniversary thereafter.